ADNP expression was also assessed in a transgenic mouse model for tauopathy, where western blot assessment at different stages in life (3–10.5 months of age) resulted in a specific age-dependent decline of ADNP in the cerebral cortex of Tau-Tg and control mice. Here, ADNP is linked to tauopathy.